Statement on the number of shares and voting rights at Sartorius Stedim Biotech

Sartorius Stedim Biotech SA has published a regulatory statement, communicating the number of shares and voting rights constituting its share capital. This information is transmitted by EQS Group.

As of September 30, 2024, Sartorius Stedim Biotech SA, based in Aubagne, France, announces a total of 97,330,405 shares comprising its share capital. The total number of theoretical voting rights, including treasury shares held by the company, amounts to 165,568,251. The number of net voting rights is 165,536,423.

This communication is in compliance with Articles L 233-8-II of the French Commercial Code and 223-6 of the AMF General Regulations. The company thus continues to comply with the regulatory obligations in force.